133 related articles for article (PubMed ID: 15529715)
21. Rofecoxib (Vioxx) withdrawal: do product monographs adequately inform physicians?
Can Fam Physician; 2005 Feb; 51(2):212-3. PubMed ID: 15751564
[No Abstract] [Full Text] [Related]
22. COX-2 inhibitors reduce knee replacement surgery problems.
Rollins G
Rep Med Guidel Outcomes Res; 2003 Dec; 14(24):1, 5-6. PubMed ID: 14677563
[No Abstract] [Full Text] [Related]
23. Rofecoxib in mild cognitive impairment.
Ownby RL
Curr Psychiatry Rep; 2006 Feb; 8(1):9-10. PubMed ID: 16513035
[No Abstract] [Full Text] [Related]
24. Cardiovascular complications of COX2 selective inhibitors cause considerable concern.
Hedner T; Himmelmann A
Blood Press; 2004; 13(5):260-1. PubMed ID: 15545147
[No Abstract] [Full Text] [Related]
25. Geriatric pharmacology: osteoarthritis.
Cuddy ML
J Pract Nurs; 2005; 55(1):6-15; quiz 16-7. PubMed ID: 15918532
[No Abstract] [Full Text] [Related]
26. Treatment of osteoarthritic pain: systemic drug therapy is not always necessary.
Prescrire Int; 2000 Dec; 9(50):168-9. PubMed ID: 11475492
[TBL] [Abstract][Full Text] [Related]
27. Patient empowerment: rofecoxib revisited.
Tannenbaum H
J Rheumatol; 2006 Jun; 33(6):1033-5. PubMed ID: 16755647
[No Abstract] [Full Text] [Related]
28. Treating pain after Vioxx. Should you switch to another COX-2, a traditional non-steroidal anti-inflammatory, or acetaminophen.
Health News; 2005 Jan; 11(1):3-4. PubMed ID: 15726703
[No Abstract] [Full Text] [Related]
29. A double-blind prospective comparison of rofecoxib vs ketorolac in reducing postoperative pain after arthroscopic knee surgery.
Kim JT; Sherman O; Cuff G; Leibovits A; Wajda M; Bekker AY
J Clin Anesth; 2005 Sep; 17(6):439-43. PubMed ID: 16171664
[TBL] [Abstract][Full Text] [Related]
30. [Severe acute cholestatic and cytolytic hepatitis induced by rofecoxib].
Ouar S; Bellaïche G; Belloc J; Tordjman G; Ley G; Slama JL
Gastroenterol Clin Biol; 2005 Apr; 29(4):471-2. PubMed ID: 15918218
[No Abstract] [Full Text] [Related]
31. Don't throw out the baby with the bathwater!
Kamen B; Kieran M
J Pediatr Hematol Oncol; 2005 Feb; 27(2):59-60. PubMed ID: 15701976
[No Abstract] [Full Text] [Related]
32. Does perioperative administration of rofecoxib improve analgesia after spine, breast and orthopaedic surgery?
Riest G; Peters J; Weiss M; Pospiech J; Hoffmann O; Neuhäuser M; Beiderlinden M; Eikermann M
Eur J Anaesthesiol; 2006 Mar; 23(3):219-26. PubMed ID: 16430794
[TBL] [Abstract][Full Text] [Related]
33. [Cardiovascular risks of Cox-2-antagonists. Opinion on the marketed name rofecoxib, and its market-withdrawn valdecoxib and the actual therapeutic restrictions].
Bolten WW; Reiter S;
Z Rheumatol; 2005 May; 64(4):286-9. PubMed ID: 15909092
[No Abstract] [Full Text] [Related]
34. Balancing the cyclooxygenase portfolio.
Armstrong PW
CMAJ; 2006 May; 174(11):1581-2. PubMed ID: 16717266
[No Abstract] [Full Text] [Related]
35. [Cardiovascular risk: a class effect of coxibs? How to manage patients taking Vioxx?].
Brune K; Zacher J
MMW Fortschr Med; 2004 Oct; 146(42):10, 12. PubMed ID: 15536697
[No Abstract] [Full Text] [Related]
36. The pain game.
Wadman M
Nature; 2007 Jul; 448(7152):400-1. PubMed ID: 17653159
[No Abstract] [Full Text] [Related]
37. Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic anti-inflammatory drugs? Arguments in favor.
Mukherjee D
Thromb Haemost; 2006 Oct; 96(4):407-12. PubMed ID: 17003915
[TBL] [Abstract][Full Text] [Related]
38. The Vioxx debacle.
Alpert JS
Am J Med; 2005 Mar; 118(3):203-4. PubMed ID: 15745713
[No Abstract] [Full Text] [Related]
39. Was Vioxx really that dangerous?
Park A
Time; 2005 Feb; 165(9):52. PubMed ID: 15765852
[No Abstract] [Full Text] [Related]
40. [Overestimated].
Höer A; Häussler B
Med Klin (Munich); 2006 Aug; 101(8):676-7; author reply 678-9. PubMed ID: 17051671
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
